Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy

Jigar S. Patel, MD, Named Chief Medical Officer

Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer

MCLEAN, Va.--(BUSINESS WIRE)-- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership team to support the company’s strategic growth, transformation and mission to bring transparency to the healthcare ecosystem with innovative products and solutions.

Jigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will provide medical guidance on the strategic development and product innovation of Claritev’s healthcare technology and network optimization solutions. Patel brings deep expertise in healthcare delivery, medical network dynamics and industry relationships. This experience will be integral as he works to align Claritev’s products with the evolving needs of the industry, including health plans, payors and other medical organizations. Prior to joining Claritev, Patel spent more than 18 years at Cerner/Oracle where he worked with large national healthcare companies on all aspects of their Healthcare Information Technology needs and strategy.

Fernando Schwartz, Ph.D., has been appointed Chief Artificial Intelligence Officer effective February 17, 2025. Schwartz leads the AI and Data Science Department on Chief Digital Officer Michael Kim’s team. Bringing 15 years of leadership in data science and machine learning, Schwartz will lead the Company’s AI and analytics strategy as well as new product development and capabilities that will benefit existing and new clients or partners. Prior to joining Claritev, Schwartz most recently served as the Vice President of AI at ADP. Before that, he led the global data science strategy for Merck’s Human Health Division as the Associate Vice President and Global Head of Data Science.

“Today’s announcement marks a pivotal moment in Claritev’s strategic transformation journey,” said Travis Dalton, Chairman, CEO and President of Claritev. “With their past industry experience and expertise, Jigar’s and Fernando’s roles will bring us a step closer to providing cutting-edge innovation and technology that promote more affordable, transparent and higher quality healthcare services.

About Claritev

Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders – including payors, employers, patients, providers, and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all.

Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250417495531/en/

Media Relations

Pamela Walker

VP, Marketing & Communication

Claritev

781-895-3118

press@claritev.com



Investor Relations

Jason Wong

SVP, Treasury & Investor Relations

Claritev

866-909-7427

investor@claritev.com



Shawna Gasik

AVP, Investor Relations

Claritev

866-909-7427

investor@claritev.com

Source: Claritev Corporation

FAQ

What strategic appointments did Claritev (CTEV) announce for 2025?

Claritev announced two key appointments: Dr. Jigar S. Patel as Chief Medical Officer (effective April 14, 2025) and Dr. Fernando Schwartz as Chief Artificial Intelligence Officer (effective February 17, 2025).

What is Dr. Jigar Patel's background before joining Claritev (CTEV)?

Dr. Jigar Patel spent over 18 years at Cerner/Oracle, working with large national healthcare companies on Healthcare Information Technology needs and strategy.

What will be Dr. Fernando Schwartz's role at Claritev (CTEV)?

As Chief AI Officer, Dr. Schwartz will lead the AI and Data Science Department, overseeing AI and analytics strategy, new product development, and capabilities for clients and partners.

How does Claritev (CTEV) plan to transform healthcare through these appointments?

These appointments aim to enhance Claritev's ability to provide cutting-edge innovation and technology for more affordable, transparent, and higher quality healthcare services.